Yegna Manojavam Drugs & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 26-12-2024
- Paid Up Capital ₹ 6.09 Cr
as on 26-12-2024
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 54.77 Cr
as on 26-12-2024
- Satisfied Charges ₹ 46.30 Cr
as on 26-12-2024
- Revenue 32.36%
(FY 2018)
- Profit 711.56%
(FY 2018)
- Ebitda -36.17%
(FY 2018)
- Net Worth 53.10%
(FY 2018)
- Total Assets -91.38%
(FY 2018)
About Yegna Manojavam Drugs & Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.09 Cr.
The company currently has active open charges totaling ₹54.77 Cr. The company has closed loans amounting to ₹46.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lakshmi Poornanandasastry, Varalakshmi Rangavajhala, Revanth Kumar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PLC041563
- Company No.
041563
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2003
- Date of AGM
28 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Yegna Manojavam Drugs & Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Poornanandasastry  | Managing Director | 22-Aug-2003 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varalakshmi Rangavajhala | Additional Director | 11-Jun-2014 | Current |
| Revanth Kumar | Additional Director | 20-Nov-2020 | Current |
| Rukmini Chilagani | Additional Director | 20-Nov-2020 | Current |
| Sreedhar Reddy | Additional Director | 20-Nov-2020 | Current |
| Mohana Ariga | Additional Director | 20-Nov-2020 | Current |
Financial Performance of Yegna Manojavam Drugs & Chemicals.
Yegna Manojavam Drugs & Chemicals Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 32.36% increase. The company also saw a substantial improvement in profitability, with a 711.56% increase in profit. The company's net worth Soared by an impressive increase of 53.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yegna Manojavam Drugs & Chemicals?
In 2018, Yegna Manojavam Drugs & Chemicals had a promoter holding of 23.04% and a public holding of 76.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Raamanjaneya Constructions Private LimitedActive 5 years 10 months
Revanth Kumar and Rukmini Chilagani are mutual person
- Online Shahar Business Solutions Private LimitedActive 3 years 9 months
Revanth Kumar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 21 Jul 2006 | ₹54.77 Cr | Open |
Indian Overseas Bank Creation Date: 25 May 2011 | ₹29.82 Cr | Satisfied |
Andhra Pradesh State Financial Corporation Creation Date: 17 Mar 2009 | ₹5.00 M | Satisfied |
How Many Employees Work at Yegna Manojavam Drugs & Chemicals?
Unlock and access historical data on people associated with Yegna Manojavam Drugs & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yegna Manojavam Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yegna Manojavam Drugs & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
